+91 789 2456 581 | info@nckpharma.com

Pharma News

Keep updating your pharma knowledge
3 Dec 2014

Top 10 biologic sales & Growth Y/Y – 2012/2013

Worldwide Top 1o Biologic sales

Ranking 2013 Ranking 2012 Brand  Lead company Molecule type Approved indication(s) 2012 Sale in Billion 2013 Sale in Billion % Change
1 1 Humira (adalimumab) AbbVie mAb Rheumatoid arthritis (RA), juvenile rheumatoid arthritis, Crohn’s disease, psoriatic arthritis (PA), psoriasis, ankylosing spondylitis, ulcerative colitis (UC), Behçet syndrome 9.3 10.7 15.5
2 2 Remicade (infliximab) J&J mAb RA, Crohn’s disease, psoriasis, UC, ankylosing spondylitis, Behçet syndrome, PA 6.6 8.9 35.6
3 3 Enbrel (etanercept) Amgen Protein RA, psoriasis, ankylosing spondylitis, PA, juvenile rheumatoid arthritis 8.0 8.3 4.2
4 Lantus Sanofi Insulin glargine Diabetes 7.6 NA
5 4 Rituxan (rituximab) Roche mAb RA, chronic lymphocytic leukemia/small cell lymphocytic lymphoma, non-Hodgkin’s lymphoma, antineutrophil cytoplasmic antibodies associated vasculitis, indolent non-Hodgkin’s lymphoma, diffuse large B-cell lymphoma 7.0 7.4 5.0
6 5 Avastin (bevacizumab) Roche mAb Colorectal cancer, non–small cell lung cancer, renal cell cancer, brain cancer (malignant glioma; anaplastic astrocytoma, glioblastoma multiforme) 6.1 6.7 10.6
7 6 Herceptin (trastuzumab) Roche mAb Breast cancer, gastric cancer 6.2 6.6 6.7
8 7 Neulasta (pegfilgrastim) Amgen Protein Neutropenia/leukopenia 4.1 4.4 7.5
9 8 Lucentis (ranibizumab) Roche mAb Wet age-related macular degeneration, diabetic macular edema, retinal vein occlusion 4.0 4.2 4.9
10 9 Avonex (interferon beta-1a) Biogen IDEC Protein Multiple sclerosis 2.9 3 3.0
10 Rebif (interferon beta-1a) Merck Protein Multiple sclerosis 2.4 NA

Leave a Reply

Scale up your Pharma knwledge to Next Level with our Free Content

Case studies & Caselets
Simulation based learning
Online self competency assessment tests 

etc.